Real world outcomes of high dose hypo-fractionated radiation therapy for mucosal head and neck cancer in patients unsuitable for curative treatment
High dose palliative-RT in patients with mucosal HNSCC not suitable for definitive chemoradiotherapy provided durable local control with low toxicities after 12 months. In-field locoregional failures were more likely for more advanced disease.
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-10-31
- DOI
- https://doi.org/10.5603/rpor.108006
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00